Robert Michael

Pharma

AbbVie plots $10B US outlay as pharma tariff threat looms

With the threat of drug tariffs sparking an investment rush in the U.S., AbbVie is laying plans to spend billions in the country over the next decade.

Fraiser Kansteiner Apr 25, 2025 11:52am

AbbVie's Rob Michael collected $18.5M in '24 CEO debut

Mar 11, 2025 1:11pm